Introduction
Calcific aortic valve disease represents the predominant pathology of tricuspid (trileaflet) and bicuspid aortic valves in developed countries (Ladich et al., 2011) . Accounting for approximately half of anatomically isolated aortic stenosis and 25 percent of patients with aortic regurgitation (Roberts, 1970) , calcific bicuspid aortic valves requiring surgical intervention present at least two decades earlier than the tricuspid counterpart (Ward, 2000) . Mechanisms important in cardiac and organ development -notably, the Notch pathway -have emerged as central players recapitulated and reused during the pathogenesis of calcific aortic valve disease, and support also a common etiology for bicuspid aortic valve and aortic valve calcification (Garg et al., 2005) (Table 1) . Active engagement of inflammatory, remodeling, neovascularization and osteogenic (Aikawa et al., 2007a; Aikawa et al., 2007b; Miller et al., 2010; Rajamannan et al., 2003) pathways has conceptually replaced 'degeneration' in calcific aortic valve disease pathogenesis and progression (Dweck et al., 2012) . Moreover, these pathways invoke similar mechanisms during cardiac morphogenesis. Dysregulated Notch activity has also been reported in vascular inflammation, macrophage activation (Fung et al., 2007) , cardiometabolic disorder, and vascular and aortic valve calcification (Fukuda et al., 2012) . Preclinical studies suggest that specific blockade of Notch ligand-receptor signaling potently suppresses vascular calcification and calcific aortic valve disease (Fukuda et al., 2012) . In this chapter, we review the mechanisms of Notch signaling, aortic valve dysmorphology pertinent to accelerated valve calcification, and discuss the pathways involving Notch that lead to aortic valve calcification and disease. 
Notch signaling
The human Notch receptor family comprises four members, Notch1 through Notch4, expressed as transmembrane molecules on the cell surface of neighboring cells that enable canonical signaling in a contact-dependent manner (Bray, 2006; Kopan and Ilagan, 2009 ). Canonical Notch signaling describes the 'classic' interaction between membrane-bound receptors and ligands expressed on the surface of neighboring (signaling and receiving) cells, whereas non-canonical signaling encompasses a diverse group of structurally unrelated ligands that contribute to the pleiotropic effect of Notch signaling (Kopan and Ilagan, 2009 ). In mammals, five members of the Delta-Serrate-LAG-2 (DSL) family have the capacity to activate or modify canonical Notch signaling -Delta-like 1 (Dll1), Dll3, Dll4, Jagged1, and Jagged2. Interaction between Notch receptor and ligand is tightly controlled, and the signaling outcome is determined by the receptor:ligand ratio (Artavanis-Tsakonas and Muskavitch, 2010; Gibert and Simpson, 2003; Heitzler and Simpson, 1991; Wilkinson et al., 1994 ) that critically determines asymmetry in cell fate and development of neighboring cells. This interaction between receptor and ligand can be modified posttranslationally through Notch glycosylation by lunatic, manic and radical glycosyltransferases (Bray, 2006) . The receptor:ligand ratio is dependent on the differential expression of competing ligands on neighboring cells in trans, as opposed to cis interaction through which receptor and ligand expressed on the same cell can also modulate Notch signaling. The complexity of receptor-ligand interaction is further increased by the requirement of heterodimerization of the receptor (Kopan and Ilagan, 2009 
Congenital aortic valve disease

Notch dysfunction in aortic valve anomalies and other congenital heart diseases
Congenital aortic valve anomalies frequently associate with other abnormalities in neighboring structures, including the aortic root (e.g. dilatation, aneurysm), aorta (e.g. coarctation of aorta), ventricular outflow tract (e.g. septal defect, transposition of great vessels), and/or coronary arteries (e.g. coronary anomalies) (Perloff, 2003; Ward, 2000) . The association of anomalies is due in part to the complexity and critical function of the endocardial cushion, and its formation during cardiac valve and septum development (Camenisch et al., 2010 ).
The tight regulation of Notch signaling during murine cardiac morphogenesis, particularly of the cardiac outflow tract and semilunar (aortic and pulmonary) valves, have been recently reviewed in detail by de la Pompa and Epstein (de la Pompa and Epstein, 2012). The evolutionarily conserved nature of Notch across mammalian species is generally recognized to be applicable to human. The highly coordinated action of Notch in progenitor cell proliferation and differentiation is instrumental during development. Earliest signs of cardiac morphogenesis occur with formation of the cardiac crescent by midline fusion of first and second heart fields that feature expression of Notch1, Dll4 and Jagged1 in the primitive endocardium In a study of two unrelated families, one of which included five generations, Garg and colleagues observed mutations in NOTCH1 that segregated with aortic valve disease, particularly with bicuspid aortic valve and aortic valve calcification; but also, to a lesser extent, with tetralogy of Fallot, ventricular septal defect, mitral atresia, double-outlet right ventricle, or hypoplastic left ventricle (Garg et al., 2005) . NOTCH1 is located on chromosome 9q34.3 and encodes the 2,556-amino acid transmembrane Notch1 receptor. Affected members of one of the families analyzed had autosomal dominant inheritance of a point mutation (R1108X) resulting from a C-to-T transition of nucleotide 3322. Another unrelated family analyzed had a single base pair deletion leading to a frameshift mutation (H1505del) at position 4515. These mutations produced truncated transcripts that are believed to undergo nonsense-mediated decay, supporting haploinsufficiency of NOTCH1 in the pathogenesis of congenital heart disease (Garg et al., 2005) . Of note, despite the high propensity to development of bicuspid aortic valve and other cardiac anomalies in individuals with the NOTCH1 mutation (R1108X) (Garg et al., 2005) , aortic valve calcification was present even in a minority of family members with the mutation who did not have bicuspid or dysmorphic aortic valves, suggesting that the penetrance of the NOTCH1 mutation is variable (or the effects compensated for by another Notch receptor or other mechanisms), and that maldistribution of mechanical stress alone can not explain accelerated valve calcification in these individuals. The complexity of gene-phenotype effects in human is highlighted by variable penetrance of JAG1 mutation (e.g. G274D missense mutation) and phenotypic expression, as demonstrated by differences in the degree of glycosylation, protein trafficking and cell-surface protein expression given the same mutation (Lu et al., 2003 
Aortic valve dysmorphology, bicuspid aortic valve and calcification
Anomalies of the aortic valve can be classified based on size, shape, the number of valve leaflets, cuspal inequality, nature of commissures (e.g. unicomissural, acquired fusion), and location of a false raphé if present (Perloff, 2003; Ward, 2000) . Unicuspid, quadricuspid and six-cuspid aortic valves occur rarely (Perloff, 2003) , and associated mutations have not been reported, unlike bicuspid aortic valves resulting from impaired Notch1 signaling (Garg et al., 2005) . Unicuspid and bicuspid aortic valves often prematurely develop valve calcification at least two decades earlier than their normal trileaflet counterpart (Pachulski and Chan, 1993) . Although maldistribution of mechanical stress contributes to the fibrocalcific process, additional factors apart from biomechanical forces including inflammatory and profibrotic processes direct the differentiation of valve fibroblasts into myofibroblasts and osteoblasts that promote osteogenesis (Dweck et al., 2012; Rajamannan et al., 2003) .
Maldistribution of shear stress on valve cusps is thought to promote calcification of the aortic valve seen in unicuspid, bicuspid, and tricuspid aortic valve with cuspal inequality (Perloff, 2003) . Bicuspid aortic valve is found in 1-2% of the general population in the United States, with a slight male predominance reported in some studies (Roberts et al., 2012; Ward, 2000) . Maldistribution of diastolic force among valve cusps and sinus attachment is thought also to promote ascending aortic dilatation or aneurysm (Burks et al., 1998; Perloff, 2003; Roberts, 1970) . However, it remains unclear whether these aortic manifestations are genetically determined or represent a byproduct of mechanical stress, given that aortic dilatation is indistinct among regurgitant, stenotic and functionally normal bicuspid aortic valves (Hahn et al., 1992) . Emerging evidence supports increased proteolytic activity in the aortic valve and adjacent areas including the aorta that may enhance the remodeling processes (Aikawa et al., 2007b) .
Valvular calcification in the early stages causes aortic sclerosis, which predicts increased risks for cardiovascular morbidity and mortality (Otto et al., 1999) . As the process progresses, the aortic valve orifice narrows while the valve anatomy and function become gradually distorted to produce valvular aortic stenosis with or without regurgitation, myocardial hypertrophic response, myocardial fibrosis, heart failure, and hemodynamic instability (Dweck et al., 2012) . In recent years, the concept of degeneration in the pathogenesis of calcific aortic valve disease has been superseded by that of phenotypic modulation recapitulating embryonic development, angiogenesis, acquired and innate immune activation, wound healing and bone formation (Hakuno et al., 2009 ) animals fed a hypercholesterolemic diet, and independently treated with IgG isotype control or anti-Dll4 monoclonal antibody (Dll4 Ab). 750-nm CLIO750 nanoparticles were used to image macrophages, and 680-nm VisEn OsteoSense680 was used for the detection of osteogenic activity (top and bottom rows). Decreased osteogenic activity in the anti-Dll4 monoclonal antibody treated specimen is visualized using alkaline phosphatase (ALP) staining (middle row). Adapted from Fukuda and colleagues (Fukuda et al., 2012 
Clinical implications
Calcific aortic valve disease in individuals with severe aortic stenosis can progress quickly after presentation with symptoms, usually portending limited short-term survival (Turina et al., 1987 
